Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice

Carla Iacobini1, Giovanna Oddi, Stefano Menini

  • 1Department of Cell Biology and Neurosciences, Istituto Superiore de Sanità, Rome, Italy.

Insights

Aging accelerates kidney damage, similar to diabetes, due to advanced glycation end-products (AGEs) and oxidative stress. Galectin-3 deficiency worsens these age-related kidney changes, highlighting the AGE/AGE receptor pathway

Area of Science:

  • Nephrology
  • Gerontology
  • Molecular Biology

Background:

  • Aging kidneys exhibit functional and structural changes similar to diabetic nephropathy.
  • Accumulation of advanced glycation end-products (AGEs) and oxidative stress contribute to age-related kidney disease.
  • Galectin-3 acts as an AGE receptor, potentially protecting against AGE-induced kidney damage.

Purpose of the Study:

  • To investigate the role of the AGE/AGE receptor pathway in age-related renal disease pathogenesis.
  • To evaluate glomerular lesion development in aging galectin-3 knockout (KO) versus wild-type (WT) mice.

Main Methods:

  • Comparative analysis of aging galectin-3 KO and WT mice.
  • Assessment of renal function (proteinuria, albuminuria) and structure (glomerular sclerosis, mesangial area).
  • Measurement of AGEs, oxidative stress markers (isoprostane, N(epsilon)-carboxymethyllysine, 4-hydroxy-2-nonenal), and NF-kappaB activity.

Main Results:

  • Aging galectin-3 KO mice exhibited significantly increased proteinuria, albuminuria, and glomerular sclerosis compared to WT mice.
  • KO mice showed greater age-dependent increases in glomerular and mesangial areas, and extracellular matrix expression.
  • Elevated levels of AGEs, oxidative stress markers, and NF-kappaB activity were observed in aging KO mice.

Conclusions:

  • Galectin-3 deficiency exacerbates age-related renal functional and structural decline.
  • Increased AGE accumulation and oxidative stress in galectin-3 KO mice contribute to accelerated kidney aging.
  • The AGE/AGE receptor pathway is implicated in the pathogenesis of age-related renal disease.

Related Concept Videos